Come up with a name for your new list and we'll add to it:
Ovid Therapeutics raised a round of funding on October 10, 2014. Investors include
DoubleLine Equity Healthcare Fund.
Ovid Therapeutics (NASDAQ: OVID) is a New York-based biopharmaceutical company using its BoldMedicine approach to develop therapies that transform the lives of patients with rare neurological diseases…